Med-Orbaix: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Med-Orbaix
Largest movements
- Cash +€39,296
up €39,296 (+47.5%), from €82,650 to €121,947
mainly Other debts (+€122,096) and Net result for the year (+€37,470)
- Receivables within one year -€5,700
down €5,700 (-39.6%), from €14,379 to €8,679
of which Other amounts receivable: -€7,005
- Tangible fixed assets -€1,700
down €1,700 (-36.7%), from €4,628 to €2,928
- Other debts +€122,096
up €122,096, from €0 to €122,096
- Reserves -€84,000
down €84,000 (-100%), from €84,000 to €0
- Tax, wage and social debts -€5,319
down €5,319 (-57.3%), from €9,290 to €3,970
- Gross operating margin +€6,572
up €6,572 (+15.0%), from €43,730 to €50,302
- Taxes +€991
up €991 (+10.6%), from €9,326 to €10,317
- Financial income -€601
down €601 (-42.8%), from €1,405 to €803
From the 2025 result to the 2026 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €104,555 | €136,822 | +€32,267 | +30.9% |
| Fixed assets | 21/28 | €4,628 | €2,928 | -€1,700 | -36.7% |
| Tangible fixed assets | 22/27 | €4,628 | €2,928 | -€1,700 | -36.7% |
| Other tangible fixed assets | 26 | €4,628 | €2,928 | -€1,700 | -36.7% |
| Current assets | 29/58 | €99,928 | €133,894 | +€33,967 | +34.0% |
| Amounts receivable within one year | 40/41 | €14,379 | €8,679 | -€5,700 | -39.6% |
| Trade receivables | 40 | €120 | €1,425 | +€1,305 | +1,088% |
| Other amounts receivable | 41 | €14,259 | €7,254 | -€7,005 | -49.1% |
| Cash at bank and in hand | 54/58 | €82,650 | €121,947 | +€39,296 | +47.5% |
| Deferred charges and accrued income | 490/1 | €2,898 | €3,269 | +€371 | +12.8% |
| Total equity and liabilities | 10/49 | €104,555 | €136,822 | +€32,267 | +30.9% |
| Equity | 10/15 | €89,626 | €5,000 | -€84,626 | -94.4% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €84,000 | €0 | -€84,000 | -100% |
| Distributable reserves | 133 | €84,000 | €0 | -€84,000 | -100% |
| Profit (loss) carried forward | 14 | €626 | €0 | -€626 | -100% |
| Amounts payable | 17/49 | €14,930 | €131,822 | +€116,892 | +783% |
| Amounts payable within one year | 42/48 | €14,930 | €131,822 | +€116,892 | +783% |
| Trade debts | 44 | €5,640 | €5,756 | +€116 | +2.1% |
| Suppliers | 440/4 | €5,640 | €5,756 | +€116 | +2.1% |
| Taxes, remuneration and social security | 45 | €9,290 | €3,970 | -€5,319 | -57.3% |
| Taxes | 450/3 | €9,290 | €3,970 | -€5,319 | -57.3% |
| Other amounts payable | 47/48 | €0 | €122,096 | +€122,096 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,700 | €1,700 | = | 0.0% |
| Other operating charges | 640/8 | €1,570 | €1,567 | -€3 | -0.2% |
| Gross operating margin | 9900 | €43,730 | €50,302 | +€6,572 | +15.0% |
| Operating profit (loss) | 9901 | €40,460 | €47,036 | +€6,576 | +16.3% |
| Financial income | 75/76B | €1,405 | €803 | -€601 | -42.8% |
| Recurring financial income | 75 | €1,405 | €803 | -€601 | -42.8% |
| Financial charges | 65/66B | €41 | €53 | +€12 | +28.8% |
| Recurring financial charges | 65 | €41 | €53 | +€12 | +28.8% |
| Profit (loss) for the period before taxes | 9903 | €41,824 | €47,787 | +€5,962 | +14.3% |
| Income taxes | 67/77 | €9,326 | €10,317 | +€991 | +10.6% |
| Profit (loss) for the period | 9904 | €32,499 | €37,470 | +€4,971 | +15.3% |
| Profit (loss) for the period to be appropriated | 9905 | €32,499 | €37,470 | +€4,971 | +15.3% |
Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.